|
1
|
Khan M, Yi F, Rasul A, Li T, Wang N, Gao
H, Gao R and Ma T: Alantolactone induces apoptosis in glioblastoma
cells via GSH depletion, ROS generation, and mitochondrial
dysfunction. IUBMB Life. 64:783–794. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khan M, Zheng B, Yi F, Rasul A, Gu Z, Li
T, Gao H, Qazi JI, Yang H and Ma T: Pseudolaric Acid B induces
caspase-dependent and caspase-independent apoptosis in U87
glioblastoma cells. Evid Based Complement Alternat Med.
2012:9575682012.PubMed/NCBI
|
|
3
|
Amantini C, Mosca M, Nabissi M, Lucciarini
R, Caprodossi S, Arcella A, Giangaspero F and Santoni G:
Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1
vanilloid receptor and requires p38 MAPK activation. J Neurochem.
102:977–990. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su Y, Li G, Zhang X, Gu J, Zhang C, Tian Z
and Zhang J: JSI-124 inhibits glioblastoma multiforme cell
proliferation through G(2)/M cell cycle arrest and apoptosis
augment. Cancer Biol Ther. 7:1243–1249. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yin D, Wakimoto N, Xing H, Lu D, Huynh T,
Wang X, Black KL and Koeffler HP: Cucurbitacin B markedly inhibits
growth and rapidly affects the cytoskeleton in glioblastoma
multiforme. Int J Cancer. 123:1364–1375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jeon JY, An JH, Kim SU, Park HG and Lee
MA: Migration of human neural stem cells toward an intracranial
glioma. Exp Mol Med. 40:84–91. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiu B, Sun X, Zhang D, Wang Y, Tao J and
Ou S: TRAIL and paclitaxel synergize to kill U87 cells and
U87-derived stem-like cells in vitro. Int J Mol Sci. 13:9142–9156.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suliman A, Lam A, Datta R and Srivastava
RK: Intracellular mechanisms of TRAIL: apoptosis through
mitochondrial-dependent and -independent pathways. Oncogene.
20:2122–2133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siegelin MD, Reuss DE, Habel A, Rami A and
von Deimling A: Quercetin promotes degradation of survivin and
thereby enhances death-receptor-mediated apoptosis in glioma cells.
Neuro Oncol. 11:122–131. 2009. View Article : Google Scholar
|
|
10
|
Siegelin MD, Reuss DE, Habel A,
Herold-Mende C and von Deimling A: The flavonoid kaempferol
sensitizes human glioma cells to TRAIL-mediated apoptosis by
proteasomal degradation of survivin. Mol Cancer Ther. 7:3566–3574.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia S, Li Y, Rosen EM and Laterra J:
Ribotoxic stress sensitizes glioblastoma cells to death receptor
induced apoptosis: requirements for c-Jun NH2-terminal
kinase and Bim. Mol Cancer Res. 5:783–792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smyth MJ, Takeda K, Hayakawa Y, Peschon
JJ, van den Brink MR and Yagita H: Nature’s TRAIL - on a path to
cancer immunotherapy. Immunity. 18:1–6. 2003.
|
|
13
|
Knight MJ, Riffkin CD, Muscat AM, Ashley
DM and Hawkins CJ: Analysis of FasL and TRAIL induced apoptosis
pathways in glioma cells. Oncogene. 20:5789–5798. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Badr CE, Wurdinger T, Nilsson J, Niers JM,
Whalen M, Degterev A and Tannous BA: Lanatoside C sensitizes
glioblastoma cells to tumor necrosis factor-related
apoptosis-inducing ligand and induces an alternative cell death
pathway. Neuro Oncol. 13:1213–1224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khan M, Qazi JI, Rasul A, Zheng Y and Ma
T: Evodiamine induces apoptosis in pancreatic carcinoma PANC-1
cells via NF κB inhibition. Bangl J Pharmacol. 8:8–14. 2013.
|
|
16
|
Wang KL, Hsia SM, Yeh JY, Cheng SC, Wang
PS and Wang SW: Anti-proliferative effects of evodiamine on human
breast cancer cells. PloS One. 8:e672972013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tu YJ, Fan X, Yang X, Zhang C and Liang
HP: Evodiamine activates autophagy as a cytoprotective response in
murine Lewis lung carcinoma cells. Oncol Rep. 29:481–490.
2013.PubMed/NCBI
|
|
18
|
Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q and
Cao P: Evodiamine inhibits STAT3 signaling by inducing phosphatase
shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett.
328:243–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rasul A, Yu B, Zhong L, Khan M, Yang H and
Ma T: Cytotoxic effect of evodiamine in SGC-7901 human gastric
adenocarcinoma cells via simultaneous induction of apoptosis and
autophagy. Oncol Rep. 27:1481–1487. 2012.PubMed/NCBI
|
|
20
|
Zhang C, Fan X, Xu X, Yang X, Wang X and
Liang HP: Evodiamine induces caspase-dependent apoptosis and S
phase arrest in human colon lovo cells. Anticancer Drugs.
21:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang C, Li S and Wang MW:
Evodiamine-induced human melanoma A375-S2 cell death was mediated
by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and
augmented by ubiquitin-proteasome inhibition. Toxicol In Vitro.
24:898–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Wu LJ, Tashino S, Onodera S and
Ikejima T: Reactive oxygen species and nitric oxide regulate
mitochondria-dependent apoptosis and autophagy in
evodiamine-treated human cervix carcinoma HeLa cells. Free Radic
Res. 42:492–504. 2008. View Article : Google Scholar
|
|
23
|
Kan SF, Yu CH, Pu HF, Hsu JM, Chen MJ and
Wang PS: Anti-proliferative effects of evodiamine on human prostate
cancer cell lines DU145 and PC3. J Cell Biochem. 101:44–56. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee TJ, Kim EJ, Kim S, Jung EM, Park JW,
Jeong SH, Park SE, Yoo YH and Kwon TK: Caspase-dependent and
caspase-independent apoptosis induced by evodiamine in human
leukemic U937 cells. Mol Cancer Ther. 5:2398–2407. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu AJ, Wang SH, Chen KC, Kuei HP, Shih
YL, Hou SY, Chiu WT, Hsiao SH and Shih CM: Evodiamine, a plant
alkaloid, induces calcium/JNK-mediated autophagy and
calcium/mitochondria-mediated apoptosis in human glioblastoma
cells. Chem Biol Interact. 205:20–28. 2013. View Article : Google Scholar
|
|
26
|
Khan M, Ding C, Rasul A, Yi F, Li T, Gao
H, Gao R, Zhong L, Zhang K, Fang X and Ma T: Isoalantolactone
induces reactive oxygen species mediated apoptosis in pancreatic
carcinoma PANC-1 cells. Int J Biol Sci. 8:533–547. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Khan M, Yu B, Rasul A, Al Shawi A, Yi F,
Yang H and Ma T: Jaceosidin induces apoptosis in U87 glioblastoma
cells through G2/M phase arrest. Evid Based Complement Alternat
Med. 2012:7030342012.PubMed/NCBI
|
|
28
|
Khan M, Li T, Ahmad Khan MK, Rasul A,
Nawaz F, Zheng Y and Ma T: Alantolactone induces apoptosis in HepG2
cells through GSH depletion, inhibition of STAT3 activation, and
mitochondrial dysfunction. Biomed Res Int. 2013:7198582013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Melguizo C, Prados J, Luque R, Ortiz R,
Rama AR, Caba O, Rodriguez-Serrano F, Alvarez PJ and Aranega A:
Modulation of multidrug resistance gene expression in peripheral
blood mononuclear cells of lung cancer patients and evaluation of
their clinical significance. Cancer Chemother Pharmacol.
71:537–541. 2013. View Article : Google Scholar
|
|
30
|
Voelkel-Johnson C: An antibody against DR4
(TRAIL-R1) in combination with doxorubicin selectively kills
malignant but not normal prostate cells. Cancer Biol Ther.
2:283–290. 2003. View Article : Google Scholar
|
|
31
|
Reis CR, van der Sloot AM, Natoni A,
Szegezdi E, Setroikromo R, Meijer M, Sjollema K, Stricher F, Cool
RH, Samali A, Serrano L and Quax WJ: Rapid and efficient cancer
cell killing mediated by high-affinity death receptor
homotrimerizing TRAIL variants. Cell Death Dis. 1:e832010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Keane MM, Ettenberg SA, Nau MM, Russell EK
and Lipkowitz S: Chemotherapy augments TRAIL-induced apoptosis in
breast cell lines. Cancer Res. 59:734–741. 1999.PubMed/NCBI
|
